Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL ALLERGIC CONJUNCTIVITIS DRUG INDUSTRY
2.1 Summary about Allergic Conjunctivitis Drug Industry
2.2 Allergic Conjunctivitis Drug Market Trends
2.2.1 Allergic Conjunctivitis Drug Production & Consumption Trends
2.2.2 Allergic Conjunctivitis Drug Demand Structure Trends
2.3 Allergic Conjunctivitis Drug Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 CPC-888
4.2.2 CVXL-0074
4.2.3 ADX-102
4.2.4 AGN-229666
4.2.5 Dexamethasone Acetate SR
4.2.6 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Clinic
4.3.2 Research Center
4.3.3 Hospital
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 CPC-888
5.2.2 CVXL-0074
5.2.3 ADX-102
5.2.4 AGN-229666
5.2.5 Dexamethasone Acetate SR
5.2.6 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Clinic
5.3.2 Research Center
5.3.3 Hospital
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 CPC-888
6.2.2 CVXL-0074
6.2.3 ADX-102
6.2.4 AGN-229666
6.2.5 Dexamethasone Acetate SR
6.2.6 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Clinic
6.3.2 Research Center
6.3.3 Hospital
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 CPC-888
7.2.2 CVXL-0074
7.2.3 ADX-102
7.2.4 AGN-229666
7.2.5 Dexamethasone Acetate SR
7.2.6 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Clinic
7.3.2 Research Center
7.3.3 Hospital
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 CPC-888
8.2.2 CVXL-0074
8.2.3 ADX-102
8.2.4 AGN-229666
8.2.5 Dexamethasone Acetate SR
8.2.6 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Clinic
8.3.2 Research Center
8.3.3 Hospital
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 CPC-888
9.2.2 CVXL-0074
9.2.3 ADX-102
9.2.4 AGN-229666
9.2.5 Dexamethasone Acetate SR
9.2.6 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Clinic
9.3.2 Research Center
9.3.3 Hospital
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Accolade Pharmaceuticals LLC
10.1.2 Aldeyra Therapeutics Inc
10.1.3 AlleCures Inc
10.1.4 Allergan Plc
10.1.5 Clevexel Pharma SAS
10.1.6 Griffin Discoveries BV
10.1.7 Ocular Therapeutix Inc
10.1.8 Ohr Pharmaceutical Inc
10.1.9 Portola Pharmaceuticals Inc
10.1.10 Re-Pharm Ltd
10.1.11 Realm Therapeutics Plc
10.1.12 Sylentis SAU
10.1.13 Xencor Inc
10.2 Allergic Conjunctivitis Drug Sales Date of Major Players (2017-2020e)
10.2.1 Accolade Pharmaceuticals LLC
10.2.2 Aldeyra Therapeutics Inc
10.2.3 AlleCures Inc
10.2.4 Allergan Plc
10.2.5 Clevexel Pharma SAS
10.2.6 Griffin Discoveries BV
10.2.7 Ocular Therapeutix Inc
10.2.8 Ohr Pharmaceutical Inc
10.2.9 Portola Pharmaceuticals Inc
10.2.10 Re-Pharm Ltd
10.2.11 Realm Therapeutics Plc
10.2.12 Sylentis SAU
10.2.13 Xencor Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
